These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 15273733)
1. PTEN can inhibit in vitro organotypic and in vivo orthotopic invasion of human bladder cancer cells even in the absence of its lipid phosphatase activity. Gildea JJ; Herlevsen M; Harding MA; Gulding KM; Moskaluk CA; Frierson HF; Theodorescu D Oncogene; 2004 Sep; 23(40):6788-97. PubMed ID: 15273733 [TBL] [Abstract][Full Text] [Related]
2. The lipid phosphatase activity of PTEN is critical for stabilizing intercellular junctions and reverting invasiveness. Kotelevets L; van Hengel J; Bruyneel E; Mareel M; van Roy F; Chastre E J Cell Biol; 2001 Dec; 155(7):1129-35. PubMed ID: 11756467 [TBL] [Abstract][Full Text] [Related]
3. PTEN coordinates G(1) arrest by down-regulating cyclin D1 via its protein phosphatase activity and up-regulating p27 via its lipid phosphatase activity in a breast cancer model. Weng LP; Brown JL; Eng C Hum Mol Genet; 2001 Mar; 10(6):599-604. PubMed ID: 11230179 [TBL] [Abstract][Full Text] [Related]
4. Cell cycle arrest by the PTEN tumor suppressor is target cell specific and may require protein phosphatase activity. Hlobilkova A; Guldberg P; Thullberg M; Zeuthen J; Lukas J; Bartek J Exp Cell Res; 2000 May; 256(2):571-7. PubMed ID: 10772829 [TBL] [Abstract][Full Text] [Related]
5. PTEN suppresses hyaluronic acid-induced matrix metalloproteinase-9 expression in U87MG glioblastoma cells through focal adhesion kinase dephosphorylation. Park MJ; Kim MS; Park IC; Kang HS; Yoo H; Park SH; Rhee CH; Hong SI; Lee SH Cancer Res; 2002 Nov; 62(21):6318-22. PubMed ID: 12414663 [TBL] [Abstract][Full Text] [Related]
6. [Inhibitory effects of tumor suppressor gene PTEN on proliferation and metastasis of breast cancer ZR-75-1 cells]. Lin GP; Li XY; Huang JW; Xiong L; Zhou KY Ai Zheng; 2007 Oct; 26(10):1069-73. PubMed ID: 17927875 [TBL] [Abstract][Full Text] [Related]
7. Protein phosphatase activity of PTEN inhibited the invasion of glioma cells with epidermal growth factor receptor mutation type III expression. Cai XM; Tao BB; Wang LY; Liang YL; Jin JW; Yang Y; Hu YL; Zha XL Int J Cancer; 2005 Dec; 117(6):905-12. PubMed ID: 15986432 [TBL] [Abstract][Full Text] [Related]
8. [Effects of PTEN gene transfection on proliferation and invasion of human bladder cancer cell line BIU87]. Zhang JH; Yang WM; Zhou SW; Chen Z Ai Zheng; 2006 May; 25(5):555-9. PubMed ID: 16687073 [TBL] [Abstract][Full Text] [Related]
10. PTEN gene transfer suppresses the invasive potential of human malignant gliomas by regulating cell invasion-related molecules. Furukawa K; Kumon Y; Harada H; Kohno S; Nagato S; Teraoka M; Fujiwara S; Nakagawa K; Hamada K; Ohnishi T Int J Oncol; 2006 Jul; 29(1):73-81. PubMed ID: 16773187 [TBL] [Abstract][Full Text] [Related]
11. Regulation of androgen receptor signaling by PTEN (phosphatase and tensin homolog deleted on chromosome 10) tumor suppressor through distinct mechanisms in prostate cancer cells. Lin HK; Hu YC; Lee DK; Chang C Mol Endocrinol; 2004 Oct; 18(10):2409-23. PubMed ID: 15205473 [TBL] [Abstract][Full Text] [Related]
12. PTEN is a negative regulator of STAT3 activation in human papillomavirus-infected cells. Sun S; Steinberg BM J Gen Virol; 2002 Jul; 83(Pt 7):1651-1658. PubMed ID: 12075083 [TBL] [Abstract][Full Text] [Related]
13. [The effects of wild-type PTEN transfection on gene expressions of glioblastomas]. Tian X; Wang J; Zhang J; Du J; Pang CS; Ho-Keung NG Zhonghua Bing Li Xue Za Zhi; 2002 Feb; 31(1):46-9. PubMed ID: 11955336 [TBL] [Abstract][Full Text] [Related]
14. The PTEN lipid phosphatase domain is not required to inhibit invasion of glioma cells. Maier D; Jones G; Li X; Schönthal AH; Gratzl O; Van Meir EG; Merlo A Cancer Res; 1999 Nov; 59(21):5479-82. PubMed ID: 10554022 [TBL] [Abstract][Full Text] [Related]
15. PTEN sensitizes prostate cancer cells to death receptor-mediated and drug-induced apoptosis through a FADD-dependent pathway. Yuan XJ; Whang YE Oncogene; 2002 Jan; 21(2):319-27. PubMed ID: 11803475 [TBL] [Abstract][Full Text] [Related]
16. Regulation of cell migration by the C2 domain of the tumor suppressor PTEN. Raftopoulou M; Etienne-Manneville S; Self A; Nicholls S; Hall A Science; 2004 Feb; 303(5661):1179-81. PubMed ID: 14976311 [TBL] [Abstract][Full Text] [Related]
17. [Role of suppressor encoprotein PTEN in IGF-1 induced activation of ERK in endometrial carcinoma cells]. Zhang YJ; Wei LH; Li XP; Wang JL Ai Zheng; 2002 Jul; 21(7):724-30. PubMed ID: 12479095 [TBL] [Abstract][Full Text] [Related]
18. PTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death. Weng LP; Smith WM; Dahia PL; Ziebold U; Gil E; Lees JA; Eng C Cancer Res; 1999 Nov; 59(22):5808-14. PubMed ID: 10582703 [TBL] [Abstract][Full Text] [Related]
19. MMAC1/PTEN inhibits cell growth and induces chemosensitivity to doxorubicin in human bladder cancer cells. Tanaka M; Koul D; Davies MA; Liebert M; Steck PA; Grossman HB Oncogene; 2000 Nov; 19(47):5406-12. PubMed ID: 11103942 [TBL] [Abstract][Full Text] [Related]
20. Nuclear PTEN-mediated growth suppression is independent of Akt down-regulation. Liu JL; Sheng X; Hortobagyi ZK; Mao Z; Gallick GE; Yung WK Mol Cell Biol; 2005 Jul; 25(14):6211-24. PubMed ID: 15988030 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]